Personalised recovery assessment often remains important after surgery
For detailed guidance on the 10 mg vial specifically, see our complete 10 mg mixing guide
While it is not yet officially approved for this use, ongoing research and clinical trials are investigating its effectiveness and safety in this new application
doi: 10.1128/IAI.05208-11 168 KumarS.StecherG.SuleskiM.SanderfordM.SharmaS.TamuraK
Additional Documentation Requirements Signed consent for semaglutide and Zofran, injection log, weight tracking, documentation of side effects, dosing rationale, and adverse event reporting
Baseline BMI eligibility was defined according to the initial BMI category of interest: overweight (25.0029.99 kg/m), obese class I (30.0034.99 kg/m), or obese class IIIII ( 35.00 kg/m)